Original Research

Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective

Shah D, Risebrough NA, Perdrizet J, Iyer NN, Gamble C, Dang-Tan T

ClinicoEconomics and Outcomes Research 2018, 10:791-803

Published Date: 14 November 2018